{"id":"W3169783075","doi":"10.1093/ecco-jcc/jjab075.035","title":"OP36 Risankizumab therapy induces improvements in endoscopic endpoints in patients with Moderate-to-Severe Crohn’s Disease: Results from the phase 3 ADVANCE and MOTIVATE studies","year":2021,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Medicine; Internal medicine; Placebo; Crohn's disease; Gastroenterology; Population; Endoscopy; Clinical endpoint; Randomized controlled trial; Clinical trial; Colonoscopy; Disease; Surgery; Pathology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003733795,0.0007939519,0.002454197,0.0002986834,0.0003084718,0.0008035203,0.0005191062,0.00107224,0.001955829],"category_scores_gemma":[0.001980325,0.0003734032,0.002693239,0.0003473845,0.0007414967,0.0006791299,0.0005321007,0.001530757,0.0002784905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004147846,"about_ca_system_score_gemma":0.000925504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004756711,"about_ca_topic_score_gemma":0.001900382,"domain_scores_codex":[0.9987375,0.000763178,0.00009883705,0.0001245646,0.000142948,0.0001329389],"domain_scores_gemma":[0.9980552,0.0005506432,0.0006219383,0.0001599518,0.0001717619,0.000440497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9228951,0.01155885,0.009966286,0.001230928,0.003355346,0.00006724835,0.0001416286,0.0004140282,0.009453297,0.0001153396,0.001139259,0.03966272],"study_design_scores_gemma":[0.4847835,0.4216562,0.08309931,0.0001294738,0.003829945,0.0001945951,0.0001060584,0.0005311658,0.002478232,0.0002105688,0.002922966,0.00005812565],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915205,0.006001185,0.0002055356,0.0002424923,0.00005469234,0.0005708597,0.000554792,0.00003295781,0.0008169538],"genre_scores_gemma":[0.994644,0.002033341,0.0007525453,0.0003863364,0.0001951354,0.0004711091,0.0009111176,0.000009875677,0.0005963715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003733795,"threshold_uncertainty_score":0.01974642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01040493349968,"score_gpt":0.2638362777060804,"score_spread":0.2534313442064004,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}